Published in Biochem Soc Trans on June 01, 2003
Neuropeptide-processing enzymes: applications for drug discovery. AAPS J (2005) 1.14
Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway. Crit Rev Eukaryot Gene Expr (2012) 1.03
New angiotensins. J Mol Med (Berl) (2008) 1.00
The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled. Cell Biochem Funct (2012) 0.96
Identification of BACE2 as an avid ß-amyloid-degrading protease. Mol Neurodegener (2012) 0.92
The renin angiotensin system in the development of cardiovascular disease: role of aliskiren in risk reduction. Vasc Health Risk Manag (2008) 0.90
Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis. Br J Pharmacol (2007) 0.90
Divergent pathways for the angiotensin-(1-12) metabolism in the rat circulation and kidney. Peptides (2012) 0.90
A peptidoglycan fragment triggers β-lactam resistance in Bacillus licheniformis. PLoS Pathog (2012) 0.87
Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer. Int J Oncol (2012) 0.77
Determination of the structure form of the fourth ligand of zinc in Acutolysin A using combined quantum mechanical and molecular mechanical simulation. J Phys Chem B (2009) 0.77
NET amyloidogenic backbone in human activated neutrophils. Clin Exp Immunol (2015) 0.76
Neprilysin regulates pulmonary artery smooth muscle cell phenotype through a platelet-derived growth factor receptor-dependent mechanism. Hypertension (2013) 0.76
Hypoxia Affects Neprilysin Expression Through Caspase Activation and an APP Intracellular Domain-dependent Mechanism. Front Neurosci (2015) 0.76
Rational redesign of neutral endopeptidase binding to merlin and moesin proteins. Protein Sci (2009) 0.76